Sinergi Inti Plastindo Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp130 (market cap 142.07B, 4.71M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 678.4B, 189.1K 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.8× Sinergi Inti Plastindo Tbk.'s market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (4.71M versus 189.1K). Which is the better fit depends on your goals.
| ESIP | RSCH | |
|---|---|---|
Market Cap | 142.07B | 678.4B |
Volume | 4.71M | 189.1K |
Lot | 47.08K | 1.89K |
Turnover | 610.61M | 48.7M |
Average Price | 129.71 | 257.54 |
Value | 610.61M | 48.7M |
Indicative Equilibrium Price | 128 | 258 |
Indicative Equilibrium Volume | 193.3K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →